Diane Gomez-Thinnes serves as Chief Commercial Officer for Better Therapeutics where she leads the team that will bring the company’s innovative prescription digital therapeutics solutions to market. Ms. Gomez-Thinnes has more than two decades of experience in the medtech, consumer care and pharmaceutical sectors with significant experience in P&L management, operations, multichannel distribution, and marketing.
Diane spent 17 years in the MedTech sector at Johnson & Johnson, ascending through strategic and commercial roles. While there, she oversaw specialty areas including plastic and reconstructive surgery, biosurgery, interventional cardiology, neurovascular, and peripheral vascular, ultimately holding the title of Worldwide President, Mentor, Johnson & Johnson’s breast aesthetics business and returned the company to global market leadership. Diane went on to serve as U.S. President for Galderma, an integrated dermatology company across aesthetics, consumer care and prescription medicines where she led a major transformation for the company and delivered double-digit growth. Diane has a passion for innovation and has driven the delivery of market-leading technologies that make a difference in the lives of patients.
Diane holds an MBA from the Kellogg School of Management, Northwestern University, and a BSE, Chemical Engineering from Princeton University.